| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 302.333 $ | +301.666 $ | -20,1 % | 2 | 3.334.441 $ | +3.333.924 $ | +29,0 % | 3 | 2.026.841 $ | +901.279 $ | +50,4 % | 7 | ||||
| iSHARES TRUST | → 0 | 2.903.496 $ | +2.903.496 $ | 1 | |||||||||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 617.579 $ | +189.085 $ | +44,1 % | 1 | ||||||||
| Tenaya Therapeutics, Inc. | TNYA | → 0 | Schwach | 472.761 $ | +294.454 $ | +165,1 % | 1 | ||||||||
| Figma, Inc. | FIG | → 0 | Schwach | 430.278 $ | +430.278 $ | 1 | |||||||||
| Cohen & Co Inc. | COHN | → 0 | 301.800 $ | +301.800 $ | 1 | ||||||||||
| Q32 Bio Inc. | QTTB | → 0 | Schwach | 265.128 $ | +65.613 $ | +32,9 % | 1 | ||||||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 236.546 $ | +236.546 $ | 1 | ||||||||||
| Vor Biopharma Inc. | VOR | → 0 | Neutral | 223.868 $ | +74.974 $ | +50,4 % | 1 | ||||||||
| Xilio Therapeutics, Inc. | XLO | → 0 | Stark | 210.442 $ | +40.690 $ | +24,0 % | 1 | ||||||||
| SURROZEN INC | → 0 | 533 $ | -134 $ | -20,1 % | 1 | 667 $ | +150 $ | +29,0 % | 1 | 517 $ | -83 $ | -13,8 % | 1 | ||
| 302.333 $ | +301.666 $ | -20,1 % | 2 | 3.334.441 $ | +3.333.924 $ | +29,0 % | 3 | 2.026.841 $ | +901.279 $ | +50,4 % | 7 | ||||